Rytary on Prescription Blue Select (S5584-001)
carbidopa-levodopa extended-release
Covered, with step therapy.
Tier 4 (non-preferred drug). Quantity limit of 360 per 30 days.
$351.17
Patient pays / month, after deductible
$812.42
Patient pays / month, before the $615.00 deductible
$1,053.51
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
RYTARY 145/36.25 mg Capsule, Extended Release at a preferred retail pharmacy, from the plan's negotiated price of $1,404.68 for a month. Other covered strengths are listed below.
Prior authNot required· Step therapy applies· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 4 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| RYTARY 95/23.75 mg Capsule, Extended Release | 4 | $352.26 | ST · 360 per 30 days |
| RYTARY 145/36.25 mg Capsule, Extended Release | 4 | $351.17 | ST · 360 per 30 days |
| RYTARY 195/48.75 mg Capsule, Extended Release | 4 | $351.82 | ST · 360 per 30 days |
| RYTARY 245/61.25 mg Capsule, Extended Release | 4 | $367.48 | ST · 300 per 30 days |
Other Parkinson's drugs on this plan
Verify with the plan before prescribing or filling. Member services: (800)565-1770. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5584-001